Shares outstanding · 2011–2025
Alnylam Pharmaceuticals shares outstanding
133M+2.4% · FY2025
Alnylam Pharmaceuticals (ALNY) reported 133M in shares outstanding for fiscal 2025, +2.4% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-06 | 133M | +2.4% | Open → |
| FY20242025-02-06 | 129M | +2.8% | Open → |
| FY20232024-02-09 | 126M | +1.6% | Open → |
| FY20222022-12-31 | 124M | +3.1% | Open → |
| FY20212022-02-04 | 120M | +2.7% | Open → |
| FY20202021-02-05 | 117M | +3.9% | Open → |
| FY20192020-02-07 | 113M | +6.0% | Open → |
| FY20182019-01-31 | 106M | +6.4% | Open → |
| FY20172018-01-31 | 99.9M | +16.1% | Open → |
| FY20162017-01-31 | 86.0M | +1.0% | Open → |
| FY20152016-01-29 | 85.1M | +1.6% | Open → |
| FY20142015-01-30 | 83.8M | +31.0% | Open → |
| FY20132014-01-31 | 63.9M | +3.3% | Open → |
| FY20122013-01-31 | 61.9M | +43.2% | Open → |
| FY20112012-01-31 | 43.2M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +8.3%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals shares outstanding |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/shares-outstandingBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007497 · February 12, 2026
{{cite web |title=Alnylam Pharmaceuticals shares outstanding — 10-K (0001628280-26-007497) |url=https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.